View all newsletters
Receive our newsletter - data, insights and analysis delivered to you
  1. News
May 12, 2020updated 12 Jul 2022 11:48am

Yourway and Firma partner on process delivery for virtual trials

Integrated premium courier and clinical packager Yourway and patient-centric home healthcare provider Firma Clinical Research have partnered to provide coordinated supply and product deliveries, as well as administration services for virtual and decentralised clinical trials.

Integrated premium courier and clinical packager Yourway and patient-centric home healthcare provider Firma Clinical Research have partnered to provide coordinated supply and product deliveries, as well as administration services for virtual and decentralised clinical trials.

Free Case Study
img

Direct-to-Patient Trials: How IRT Plays an Important Role in Bellerophon's Direct-to-Patient Trials

As the industry strengthens its focus on patient centricity, Direct-to-Patient clinical trials have emerged as a popular trial design that have the potential to increase patient recruitment and retention. IRT plays a crucial role in the success of a Direct-to-Patient trial. Because drug supplies are being managed and shipped from distribution facilities directly to patients’ homes, a sponsor must have a high-quality system in place to accurately track the chain of custody, ensure patient-blinding and handle other logistical challenges. What You Will Learn Benefits and challenges associated with the Direct-to-Patient model Bellerophon's top considerations when implementing this trial design How IRT can equip study teams to successfully track chain of custody, ensure patient blinding, and handle logistical challenges
by Suvoda
Enter your details here to receive your free Case Study.

The strategic collaboration is aimed at patient retention and compliance, while also helping contract research organisations (CROs) and sponsors improve clinical trial management efficiency.

Yourway president Gulam Jaffer said: “Yourway has served the biopharma industry for more than two decades, and we are proud to collaborate with Firma Clinical to help improve the patient experience for in-home health visits for clinical trials.

“We offer direct-to-patient and direct-from-patient services globally, including shipments that require ambient to frozen temperatures and controlled substances. These services are making virtual and decentralised clinical trials possible.”

Under the partnership, the two companies are working towards a seamless process for coordinated supply delivery and drugs needed for in-home health visits to patients.

According to Yourway, both clinical products and equipment are coordinated to be sent directly to the patient seeking for in-home health visits.

Collected bodily samples and other materials are shipped from the patient’s home via a courier.

This patient-centric approach assures delivery, protocol compliance, and helps maintains data quality.

Firma Clinical Research CEO Michael Woods said: “Firma is committed to the needs of patients, sponsors and healthcare professionals by providing in-home care for clinical trials that often involve investigational products (IP).

“Firma has completed thousands of home health visits in 45 countries, and about 40% include the administration of IPs. We take a patient-centric approach to our services and often work with advocacy groups to collect patient survey data for sponsors.”

Related Companies

Free Case Study
img

Direct-to-Patient Trials: How IRT Plays an Important Role in Bellerophon's Direct-to-Patient Trials

As the industry strengthens its focus on patient centricity, Direct-to-Patient clinical trials have emerged as a popular trial design that have the potential to increase patient recruitment and retention. IRT plays a crucial role in the success of a Direct-to-Patient trial. Because drug supplies are being managed and shipped from distribution facilities directly to patients’ homes, a sponsor must have a high-quality system in place to accurately track the chain of custody, ensure patient-blinding and handle other logistical challenges. What You Will Learn Benefits and challenges associated with the Direct-to-Patient model Bellerophon's top considerations when implementing this trial design How IRT can equip study teams to successfully track chain of custody, ensure patient blinding, and handle logistical challenges
by Suvoda
Enter your details here to receive your free Case Study.

NEWSLETTER Sign up Tick the boxes of the newsletters you would like to receive. Key drug pipeline and competitive landscape changes based on the latest clinical activity, sent every Tuesday. Curated analysis and data-driven insights on clinical trials strategy and operations, sent every Thursday. The pharmaceutical industry's most comprehensive news and information delivered every month.
I consent to GlobalData UK Limited collecting my details provided via this form in accordance with the Privacy Policy
SUBSCRIBED

THANK YOU

Thank you for subscribing to Clinical Trials Arena